tirzepatide chemical structure Development of and the corresponding Tirzepatide | Excenen PharmaTech

Logue, S

Any person with the signs or symptoms of a B12 deficiency should pay a visit to their doctor, but an injection may still provide them with benefits

For individuals using GLP-1 for weight management, learning about dietary and lifestyle options may complement their medication regimen

The Noom app has introduced features to enhance the user experience of food logging

The pipeline continues to expand: Novo Nordisk filed an NDA for CagriSema (semaglutide + cagrilintide) in December 2025, which achieved 22.7% weight loss in the REDEFINE 1 trial, and Eli Lilly reported Phase 3 results for retatrutide , a triple GIP/GLP-1/glucagon agonist that delivered 28.7% weight loss

Endocrine Practice ( Endocr Pract )